Failure to vaccinate newborns with the Bacillus Calmette-Guérin (BCG) vaccine puts them at serious risk of developing ...

Academic researchers in Massachusetts believe the standard BCG (bacillus Calmette-Guérin) vaccine could have a remarkable second use: a treatment to reverse advanced type 1 diabetes.

New global study shows childhood vaccine coverage stalled by COVID-19, with urgent need to boost immunisation by 2030 to meet WHO targets.

The Bacille Calmette–Guérin (BCG) vaccine, originally developed for tuberculosis prevention, has garnered considerable attention for its capacity to reprogramme the innate immune system. Beyond ...

Bacille Calmette-Guérin revaccination shows no efficacy in preventing sustained Mycobacterium tuberculosis infection compared with placebo in adolescents in a phase 2b study.

A new study has cast a sobering light on Uganda’s immunization efforts, revealing alarmingly high levels of vaccine wastage ...

Trained immunity in alveolar macrophages can lead to damaging lung inflammation, confirming the importance of context in this phenomenon.

The story of tuberculosis goes back to the start of recorded human history, and since the 1800s it’s estimated it has been responsible for over 1 billion deaths. In New Zealand today we don’t have ...

Sam S. Chang MD, MBA, discusses intravesical mitomycin in low-grade intermediate-risk nonmuscle-invasive bladder cancer vs ...

Since 2010, progress in vaccine coverage has stalled or reversed in many countries, with measles vaccination declining in 100 ...

Puducherry has emerged as a frontrunner in Tuberculosis (TB) testing, ramping up examinations of presumptive TB patients from 2,233 per lakh population in 2015 to 2,526 per lakh in 2024, officials ...

Ministry of Health Principal Secretary Dr. Ouma Oluga receiving a batch of 3 million doses of BCG vaccine at Jomo Kenyatta International Airport on June 11, 2024. [Kanyiri Wahito, Standard] ...